Targeted Market ANiGENT operates in hospitals and health care with a focused product MAAP Analytics for drug diversion detection, suggesting a primary sales opportunity with health systems and hospital networks looking to improve medication safety, compliance, and operational efficiency.

Clinical Provenance Product is clinician-built and clinically refined, highlighting credibility with health care stakeholders. Leverage this to position MAAP Analytics as a trusted, field-tested solution for risk mitigation, incident reduction, and root-cause analysis.

ML Enabled Platform combines human intelligence with machine learning to monitor all users, medications, and locations, enabling a scalable value proposition for large hospital campuses and multi-site health systems seeking comprehensive surveillance and analytics.

Growth Readiness Revenue is reported between $1M and $10M with a small employee base, indicating a potentially agile, install-base expansion opportunity through strategic partnerships, channel selling, or enterprise licenses to accelerate scale.

Tech Ecosystem Existing tech stack and compliance tools (OneTrust, Open Graph, Piwik PRO, Microsoft 365) suggest easy integration pathways and data governance alignment, enabling a smoother procurement cycle for hospital IT and information security teams.